Nasus Pharma Ltd
NSRX$36M
Micro CapNASDAQPharmaceutical Preparations🇺🇸North AmericaTEL AVIV - YAFO1 employees
Drugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
1
Next Catalyst
Jun 24, 2026
4dMarket Overview
Stock performance and key metrics
NSRX News
Catalyst Timeline
1 upcoming, 0 past
EarningsNext
NSRX Earnings Report
Jun 24, 2026Confirmed
EPS Est: $-0.27 | FQ end 2026-03
Drug Pipeline
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
A: Epinephrine injection | Phase 2 | Anaphylaxis | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply